Fidelity National Financial heads into its May 6 Q1 2026 print with short sellers adding pressure — but the lending market suggests the move is tactical rather than structural.
Short interest has climbed sharply, rising 30% over the past month to 3.1% of the free float. The build accelerated through late April, with shares short jumping another 7% in a single week. That is a meaningful rate of change for a stock where SI had been anchored well below 3% for most of March. Yet borrowing conditions have actually eased. Cost to borrow has fallen 33% over the past week to just 0.32%, and availability in the lending pool remains wide — a combination that tells you shorts are facing no friction entering the position. There is no squeeze pressure here.
Options positioning has turned less defensive than it was. The put/call ratio has dropped sharply from extreme highs near 6.7 in early April to 1.75 now, more than one standard deviation below its 20-day average of 3.6. That dramatic reset suggests the hedging frenzy of early April — possibly triggered by the broader market selloff — has unwound fast. The stock itself has recovered 11% over the past month to $51.63, clawing back ground after a rough start to the year where it remains down roughly 5% YTD.
Analysts lean constructive but have been trimming targets. Keefe, Bruyette & Woods maintained an Outperform in early April while cutting its target from $71 to $67. Barclays, sitting at Equal-Weight, lowered its number from $63 to $54 around the same time. Both moves point to the same message: the bull case is intact but the valuation bar has come down with the macro environment. The consensus mean target of $64.60 implies about 25% upside from the current price — a gap that keeps the stock interesting for holders but reflects genuine uncertainty about the near-term earnings backdrop. The PE has expanded about a turn over the past month to roughly 8.5x, while EV/EBITDA has edged lower, pointing to a market still weighing volume recovery in title insurance against macro headwinds in housing.
History adds a cautionary note. The last two earnings prints both produced immediate declines, with the stock falling around 6-7% on the day. The five-day reaction deepened further each time. The May 6 report will therefore test whether the recent 11% recovery has priced in better-than-feared results — or whether, once again, the numbers disappoint a market still hoping for clarity on transaction volumes.
See the live data behind this article on ORTEX.
Open FNF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
